When did Ginkgo Bioworks report Q4 2024 earnings?

Ginkgo Bioworks (DNA) reported Q4 2024 earnings on February 25, 2025 after market close.

What were Ginkgo Bioworks's Q4 2024 revenue and EPS?

Ginkgo Bioworks reported revenue of $43.8M and eps of $-1.82 for Q4 2024.

Did Ginkgo Bioworks beat estimates in Q4 2024?

Revenue beat the consensus estimate of $38.7M by $5.2M. EPS missed the consensus estimate of $-1.45 by $0.37.

Where can I find Ginkgo Bioworks's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001628280-25-007819) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ginkgo Bioworks DNA Q4 2024 Annual earnings

Reported February 25, 2025 · After market close

Revenue$43.8MBeat by $5.2M

EPS-$1.82Miss by $0.37

Revenue estimate$38.7M

EPS estimate-$1.45

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$24.1M

EPS estimate-$0.90

Financials

Q4 2024

Income statement

See full

Revenue$43.8M+26.2%

Operating income-$103.6M+41.8%

Net income-$107.5M+49.2%

EPS (diluted)-$1.96+54.2%

Balance sheet

See full

Cash & equivalents$605.7M-38.8%

Total debt$467.8M+93.1%

Total equity$716.1M-34.7%

Total assets$1.4B-17.3%

Cash flow

See full

Operating cash flow-$42.4M+26.6%

CapEx$13.7M+298%

Free cash flow-$56.1M+8.4%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$564.44M-84.2%

Enterprise value$426.46M-84.9%

P/S2.5×-11.8×

Profitability

See full

Operating margin-246.5%-54.4pp

Net margin-240.9%-58.6pp

FCF margin-168.3%+58.7pp

Returns & leverage

See full

Return on equity-60.3%-2.5pp

Debt / equity0.7×+0.4×

Current ratio5.6×-0.5×

Versus estimates

Revenue

Q1 2026$19.5MMiss by $23.5M Q4 2025$33.0MMiss by $4.1M Q3 2025$38.8MBeat by $1.3M Q2 2025$49.6MBeat by $10.7M Q1 2025$48.3MBeat by $6.7M

Q4 2024$43.8MBeat by $5.2M

Diluted EPS

Q1 2026-$1.28Miss by $0.07 Q4 2025-$1.42Beat by $0.38 Q3 2025-$1.45Miss by $0.21 Q2 2025-$1.10Beat by $0.34 Q1 2025-$1.58Miss by $0.35

Q4 2024-$1.82Miss by $0.37

Ask the moment Ginkgo Bioworks reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Ginkgo Bioworks report Q4 2024 earnings?: Ginkgo Bioworks (DNA) reported Q4 2024 earnings on February 25, 2025 after market close.
What were Ginkgo Bioworks's Q4 2024 revenue and EPS?: Ginkgo Bioworks reported revenue of $43.8M and eps of $-1.82 for Q4 2024.
Did Ginkgo Bioworks beat estimates in Q4 2024?: Revenue beat the consensus estimate of $38.7M by $5.2M. EPS missed the consensus estimate of $-1.45 by $0.37.
Where can I find Ginkgo Bioworks's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001628280-25-007819) directly on SEC EDGAR. The filing index links above go to sec.gov.